The influence of monoclonal antibodies for cancer treatment on the endocrine system
Authors
Kamil Dyrka
Student’s Scientific Group of Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
Daria Witasik
Student’s Scientific Group of Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
Agata Czarnywojtek
Chair and Department of Pharmacology, Poznan University of Medical Sciences, Poznan, Poland
Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
Katarzyna Łącka
Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, Poznan, Poland
DOI: https://doi.org/10.5604/01.3001.0014.8889 | Journal eISSN: 1732-2693
Language: English
Page range: 317 - 327
Submitted on: Nov 15, 2020
Accepted on: Feb 26, 2021
Published on: May 18, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Related subjects:
© 2021 Kamil Dyrka, Daria Witasik, Agata Czarnywojtek, Katarzyna Łącka, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.